Dr. Brian Greenwell, MD
Internal Medicine, Hematology and Medical Oncology
Dr. Brian Greenwell is board certified in Internal Medicine, Hematology and Medical Oncology. He earned his B.Sc. in Chemical Engineering from Clemson University and subsequently his M.D. from the Medical University of South Carolina in 2012. He then completed his Residency in Internal Medicine at Barnes-Jewish Hospital/Washington University in St. Louis and his Fellowship in Hematology and Medical Oncology at Emory University’s Winship Cancer Institute, which he completed in 2018. On completion of his fellowship training, he worked as a faculty member at the Medical University of South Carolina where he was a Disease Focus Group Leader for the Malignant Hematology and Bone Marrow Transplant Group as well as developed and led South Carolina’s first Cutaneous Lymphoma Multidisciplinary Clinic. He was promoted to Associate Professor prior to joining Charleston Oncology in 2024.
Dr. Greenwell’s accomplishments also include selection to the Lymphoma Research Foundation Clinical Scholars Program, and previously serving as Chief Fellow during his time at Emory University. He has made significant contributions to scientific literature, served as site primary investigator on multiple clinical trials, and served on various manuscript review and grant review committees, including grants funded by the American Cancer Society.
Dr. Greenwell is driven to provide the highest levels of care to his patients, incorporating the latest immune-based, targeted, and cellular therapies into treatment paradigms for patients.
Choose your preferred location
West Ashley
North Charleston
Downtown
Summerville
Mt. Pleasant
Walterboro
Send UsA Message
Early-Stage Breast Cancer Characteristics and Treatment Options
Early-Stage Breast Cancer Characteristics and Treatment OptionsA rise in early-stage breast cancer diagnosis may result from better screening technology and a raised awareness of the importance of annual mammograms. An early-stage breast cancer diagnosis is contained...
Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World
Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”
Lowcountry doctors, patients helped secure ‘game-changer’ cancer treatment approval
Clinical trials for a newly-approved cancer treatment for lung cancer in the Lowcountry helped get the drug ready for people around the world, Lowcountry medical officials say.
Lowcountry Breast Cancer Survivors On Finding The Right Oncology Practice
How should one go about finding the right oncology practice? We interviewed ten Lowcountry breast cancer patients to get their perspectives and advice.
Sarcoma and Bone Cancer Awareness
July is Sarcoma and Bone Cancer Awareness Month. Sarcomas are a rare group of cancers in which malignant cells form in the bones or soft tissues of the body.
May is Skin Cancer Awareness Month
Melanoma is a type of skin cancer that develops when melanocytes start to grow out of control. Watch a video to learn more about melanoma from Dr. Charles S. Holladay.
